Kymera Therapeutics (KYMR) Interest Paid (2020 - 2026)
Kymera Therapeutics (KYMR) reported Interest Paid of $55,000 for Q2 2026, down 28.6% from $77,000 a year earlier and down 15.4% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Interest Paid (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kymera Therapeutics' Interest Paid came in at $278,000, up 3.0% year-over-year; for FY2025, it was $312,000, up 51.5% from FY2024.
- Interest Paid has a five-year compound annual growth rate of 22.1% (FY2020 to FY2025).
- By year, Interest Paid came in at $206,000 in FY2024 (+27.2%), $162,000 in FY2023 (-9.5%), $179,000 in FY2022 (+13.3%) and $158,000 in FY2021 (+37.4%).
- The Q2 2026 figure ranks as the lowest quarterly Interest Paid since Q3 2024.
- Year over year, Interest Paid gained in six of the last eight quarters, with growth averaging 31.7%.
- The high point for year-over-year Interest Paid in five years was Q3 2021 (growth of 126.1%); the low point was Q2 2023 (a decline of 35.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $65,000 (Q1 2026), $75,000 (Q4 2025) and $83,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Paid (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -1.78 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 283.00 Mn |
| 10 | Kymera Therapeutics | 11.66 Bn | 8.50 Bn | - | 46,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 46,000.00 |
| Jun 30, 2026 | 55,000.00 |
| Mar 31, 2026 | 65,000.00 |
| Dec 31, 2025 | 75,000.00 |
| Sep 30, 2025 | 83,000.00 |
| Jun 30, 2025 | 77,000.00 |
| Mar 31, 2025 | 77,000.00 |
| Dec 31, 2024 | 62,000.00 |
| Sep 30, 2024 | 54,000.00 |
| Jun 30, 2024 | 41,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Dec 31, 2023 | 47,000.00 |
| Sep 30, 2023 | 37,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Mar 31, 2023 | 52,000.00 |
| Dec 31, 2022 | 55,000.00 |
| Sep 30, 2022 | 38,000.00 |
| Jun 30, 2022 | 40,000.00 |
| Mar 31, 2022 | 46,000.00 |
| Dec 31, 2021 | 52,000.00 |
API Access
Kymera Therapeutics Interest Paid API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-paid&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-paid", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-paid&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();